Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:immunotherapy
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:atccode |
J05 AE01
|
| gptkbp:brand |
Invirase
|
| gptkbp:casnumber |
127779-66-0
|
| gptkbp:chemical_formula |
C29 H45 N3 O5 S
|
| gptkbp:developed_by |
gptkb:Hoffmann-La_Roche
|
| https://www.w3.org/2000/01/rdf-schema#label |
Saquinavir
|
| gptkbp:mechanism_of_action |
protease inhibitor
|
| gptkbp:route_of_administration |
oral
|
| gptkbp:used_for |
treatment of HIV
|
| gptkbp:bfsParent |
gptkb:HIV_protease_inhibitors
gptkb:Burroughs_Wellcome |
| gptkbp:bfsLayer |
6
|